November, known as Movember, is dedicated to raising awareness about men’s health issues, particularly prostate cancer. This condition has become a significant public health concern in Hong Kong and globally, underscoring the importance of understanding the latest screening techniques, their advantages and drawbacks, and the factors influencing prostate health.
Prostate cancer is the third most common cancer among men in Hong Kong. In 2022, there were 2,758 new cases diagnosed, reflecting a 69% increase in diagnoses since 2012. With a median age of diagnosis at 71 years and a five-year survival rate of 84%, the importance of early detection cannot be overstated. Globally, prostate cancer is now one of the most diagnosed cancers among men, surpassing even lung cancer in some regions.
A recent 20-year study presented at the European Association of Urology (EAU) Congress revealed a stark reality: men who skip prostate cancer screenings face a 45% higher risk of death than those who attend screenings. This study, which followed 161,000 men across seven countries, confirmed that those who attended screenings had a 23% lower risk of dying from prostate cancer. Alarmingly, over 12,400 men in the study skipped all screening appointments, facing the highest mortality risk.
Despite clear evidence that early detection saves lives—long-term data shows that PSA screening can reduce mortality rates from prostate cancer by 20%—a significant portion of at-risk men avoid screenings. This resistance not only costs lives but also increases the burden of advanced cancer treatment on healthcare systems worldwide.
Early detection plays a crucial role in effectively managing prostate cancer. When diagnosed at an early stage, the chances of successful treatment significantly improve. Traditional screening methods, particularly PSA testing, have been instrumental in identifying prostate cancer before it progresses to more advanced stages.
The Prostate-Specific Antigen (PSA) test is a blood test that measures the level of PSA, a protein produced by the prostate.
In addition to traditional PSA testing, MRI scans—both plain and contrast-enhanced—are increasingly being integrated into prostate cancer screening programs.
Several factors increase the risk of prostate cancer:
Symptoms may include:
If you experience these symptoms, consult a healthcare provider for evaluation.
Emerging research suggests that Vitamin D may play a role in prostate health, with some studies indicating that adequate levels could be associated with a reduced risk of prostate cancer.
As we observe Movember, it’s vital to prioritize men’s health by understanding prostate cancer and the latest screening techniques. Public health initiatives aimed at raising awareness about prostate cancer and the importance of screening are critical. Addressing the psychological and logistical barriers that prevent men from attending screenings is essential. Let’s work together to break the stigma and promote proactive health measures this Movember—because early detection can save lives.
Dr. Greig is a general surgeon with 26 years of experience in Hong Kong. He contributes to scientific literature, publishes weekly patient newsletters and serves as a well-being educator and communicator, collaborating with prominent institutions and companies.
Want the latest insights and fresh content delivered straight to your inbox? Subscribe to our newsletter and stay updated with our exclusive content!